‘Belviq’ has rapidly become a leader
The power of an obesity treatment approved by the FDA was tremendous. Belviq, an obesity treatment first launched by Ildong Pharmaceutical on March, recorded KRW 6 billion sales in 4 months since its launch, rapidly becoming a leading product in the market.
In this market where there has been no...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
